Director, Nonclinical Safety, Pathology

Scorpion Therapeutics

United States

Hybrid

USD 150,000 - 210,000

Full time

14 days+

Application generator

An application made for this job — a tailored resume and cover letter that speak straight to the posting.

Get past ATS filters

Job summary

Gilead is seeking a Veterinary anatomic pathologist to support nonclinical safety studies in drug development. The role involves interpreting and integrating complex pathology findings across molecular modalities and across therapeutic areas, with collaboration across cross-functional teams.

There is potential for involvement in due diligence, project leadership, and scientific initiatives. Ideal candidates hold a DVM and PhD (preferred), with 3–7 years of industry experience and board

Qualifications

DVM degree and PhD preferred.
Board-certified in anatomic pathology.
3–7 years of industry experience.
Strong data analysis and communication skills.
Experience in immunology, virology, or oncology desirable.

Responsibilities

Interpret and communicate complex pathology findings across modalities.
Collaborate with cross-functional teams on projects.
Participate in due diligence, project leadership, and scientific initiatives.

Skills

Data analysis

Problem solving

Communication skills

Collaboration

Immunology experience

Education

DVM

PhD

Tools

Digital pathology/AI

Job description

Role

Veterinary anatomic pathologist supporting nonclinical safety studies in drug development at Gilead.

Responsibilities

interpret, integrate, and communicate complex pathology findings across molecular modalities and therapeutic areas; collaborate with cross-functional teams; participate in due diligence, project leadership, and scientific initiatives.

Requirements

DVM + PhD (preferred), 3–7 years industry-related experience; board-certified in anatomic pathology; strong data analysis, problem-solving, and communication skills; experience in immunology, virology, or oncology highly desirable.

HighValue